TrialPath
← Back to searchRecruiting

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

NCT07210580 · VA Office of Research and Development
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease: A Hybrid Effectiveness-Implementation Study
About this study
Inflammatory bowel disease (IBD) is a chronic autoimmune disorder that affects over 60,000 Veterans and leads to highly symptomatic flares and complications. Close monitoring and timely treatment adjustment can stop the natural progression of IBD, improving health-related quality of life (HRQOL) and reducing flares and hospitalizations. However, it is difficult to closely monitor Veterans with IBD between clinic visits. There is a critical need for systematic solutions to support close between visit monitoring of Veterans with IBD without which they will continue to experience preventable impairment and disability. Measurement-based care (MBC) is a systematic approach to collect, share, and act on patient reported outcome (PRO) data that can be used to achieve close monitoring. MBC works by facilitating early recognition of clinical deterioration and timely clinician-driven treatment adjustment. MBC also increases patients' self-efficacy, their confidence in their ability to handle their symptoms and disease. This project will use a Hybrid Type 1 effectiveness-implementation randomized trial design (n=250 Veterans with IBD) to test the effectiveness of MBC in IBD versus enhanced treatment as usual (E-TAU) on HRQOL and IBD-related events over 12-months and identify barriers and facilitators to MBC in IBD to inform its implementation in practice. The hypothesis is that at 12-month follow-up, Veterans randomized to MBC will have greater improvement in HRQOL and fewer IBD-related events (composite of flares, emergency department visits, hospitalization, surgery) than E-TAU. The primary objective is to test the effectiveness of MBC vs. E-TAU on key patient outcomes: IBD-specific patient reported HRQOL (primary outcome) and IBD-related events obtained via electronic health record data (secondary outcome). The secondary objective is to assess determinants of MBC in IBD implementation and acceptability with process evaluation.
Eligibility criteria
Inclusion Criteria: Inclusion criteria for Veteran patients include: * receiving IBD care at one of the four sites * reporting an impaired IBD-specific HRQOL using the Short IBD Questionnaire (SIBDQ\<60, as used by others) * willingness and ability to participate in study procedures Clinic staff criteria: * relevant clinic staff (gastroenterologists, advanced practice providers, nurses) involved in MBC in IBD at the four study sites (Ann Arbor, Atlanta, Houston, Portland). Exclusion Criteria: Veteran Patient Exclusion criteria: * Presence of an ostomy or ileal-pouch anal anastomosis * Severe comorbid medical condition that can confound PRO scores and treatment priorities (e.g., cancer, transplant). * Exclusions can be readily determined from chart review and a baseline patient assessment Clinic staff exclusion criteria: * Clinic staff without any experience with MBC in IBD.
Study design
Enrollment target: 250 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-03-09
Estimated completion: 2029-09-30
Last updated: 2026-03-11
Interventions
Behavioral: MBC-IBD InterventionOther: Enhanced Treatment as Usual (E-TAU)
Primary outcomes
  • Patient-reported Health-related Quality of Life (Baseline compared to 12 month follow-up.)
Sponsor
VA Office of Research and Development · fed
Contacts & investigators
ContactShirley Cohen-Mekelburg, MD MS · contact · Shirley.Cohen-Mekelburg@va.gov · (734) 845-5082
ContactNicolle Marinec, MPH · contact · Nicolle.Marinec@va.gov · (734) 845-3653
InvestigatorShirley Cohen-Mekelburg, MD MS · principal_investigator, VA Ann Arbor Healthcare System, Ann Arbor, MI
All locations (4)
Atlanta VA Medical and Rehab Center, Decatur, GANot Yet Recruiting
Decatur, Georgia, United States
VA Ann Arbor Healthcare System, Ann Arbor, MIRecruiting
Ann Arbor, Michigan, United States
VA Portland Health Care System, Portland, ORNot Yet Recruiting
Portland, Oregon, United States
Michael E. DeBakey VA Medical Center, Houston, TXNot Yet Recruiting
Houston, Texas, United States
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease · TrialPath